A closely cropped shot of two women with their arms intertwined



Innovate UK logo

嘉樂麗臨床護理及其母公司得到了英國政府創新機構 Innovate UK 的慷慨支持。
2021 年 11 月,該機構確認授予本公司額外的經費,以推進研發工作。

University Hospitals Coventry & Warwickshire

CLCC has designed an in-woman trial of our device with progesterone, working closely with the Clinical Trials Unit from University Hospitals Coventry & Warwickshire (UHCW). This is led by Professor Siobhan Quenby, our clinical co-lead and one of the world’s foremost authorities on miscarriage and preterm birth prevention. Siobhan led the highly-cited Lancet series (2021) on miscarriage and was co-applicant, major recruiter to and co-author on the two largest and most significant trials of vaginal progesterone to prevent miscarriage (PROMISE and PRISM). The results of these trials led to the UK’s NICE updating its miscarriage guideline, to now recommend women at high risk of miscarriage to take vaginal progesterone twice daily for up to 80 days – guidance that has subsequently been adopted in Australia and we believe is being closely followed in other countries, with potential to further expand the market opportunity for this indication

欲了解更多關於合作夥伴關係,或其他業務發展機會的資訊,請發送電郵至 info@callali.ly或致電 +44(0)20 7754 5400

我們使用 cookies 來增強您的網站體驗。我們使用必要的 cookies 來確保我們的網站功能正常,並保持其安全性。這些 cookies 需要一直開啟。透過點擊「接受 Cookies」,同意Cookies 儲存您的設備,以增強網站導航,分析網站使用情況,並協助我們的營銷工作。請參閱我們的私隱政策獲取更多詳情。